5 Stocks to Watch: Week of 9/14/2026

By Jessie Moore, Stock Researcher and Writer
September 11, 2026 4:50 PM UTC
5 Stocks to Watch: Week of 9/14/2026

We've put together an exceptional list of stocks this week if we do say so ourselves...

  • Semtech (SMTC): Experts believe there’s over 100% upside ahead (!!) 
  • Amneal Pharmaceuticals (AMRX): A low-priced stock that analysts love
  • EnerSys (ENS): A top 3% analyst sees over 50% upside
  • Hewlett Packard Enterprise (HPE): Ten Strong Buys + riding the AI infrastructure wave
  • Jones Lang LaSalle (JLL): #1 in its industry with an A for Financials


A note from our sponsors...

10 AI Infrastructure Stocks to Watch

Free report reveals 10 publicly traded companies positioned across key layers of the AI ecosystem, from chip fabrication and custom silicon to data storage, connectivity, and cooling solutions. Plus insight into the major risks that could impact the AI infrastructure trade, including valuation concerns, industry cycles, geopolitical challenges, and execution risks.

Get your FREE copy here.


 

1- Jones Lang LaSalle Inc (NYSE: JLL)

JLL helps companies buy, sell, lease, and manage commercial real estate. A rebound in property deals plus booming data center demand is lifting activity, giving investors exposure to a recovering real estate market with an AI infrastructure tailwind.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $342.16 — get current quote

Max 1-year forecast: $445.00

Why we're watching:

  • JLL has limited, but overall bullish, coverage among the analysts we track, with 1 Strong Buy, 1 Buy, and 1 Hold recommendation. See all recommendations here
  • For example, UBS researcher Alex Kramm (a top 12% rated analyst) maintained his Strong Buy rating with a price target suggesting the stock could see over 30% upside from current levels. Keefe, Bruyette & Woods researcher Jade Rahmani (a top 15% rated analyst) maintains a similar price target. 
  • Industry ranking context: JLL is currently the #1 highest-rated stock in the Real Estate Service industry, which has an Industry Rating of C.
  • Zen Ratings highlights: JLL earns an overall A rating, which translates to a Strong Buy recommendation. Stocks in this elite category have historically outperformed the market with nearly 30% average annual returns.
  • Component Grades: JLL shines with an A for Financials, reflecting the company's strong balance sheet and operational efficiency, while maintaining solid Bs for Growth, Sentiment, and Value that position it well for sustained appreciation. See all 7 Component Grades here


A note from our sponsors...

Could a $100 Options Trade Become $1,000+?

It's possible, and this new report shows you how traders approach it. Inside, you'll discover a simple system for spotting low-priced options trades with outsized gain potential. You'll learn the core vocabulary, how calls and puts work, the risk factors to weigh before every trade, and practical examples to follow. Download the report now.

Download the report now


2- Amneal Pharmaceuticals (NASDAQ: AMRX)

Amneal Pharmaceuticals is a diversified pharmaceutical company involved in the development, licensing, manufacturing, marketing, and distribution of generic and specialty medications. The company's expanding specialty portfolio and improving operational efficiency are driving accelerating earnings growth, with new product launches expected to provide additional revenue momentum.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $16.87 — get current quote

Max 1-year forecast: $25.00

Why we're watching:

  • AMRX has limited, but overwhelmingly bullish, coverage among the analysts we track, with 3 Strong Buy, and 1 Buy recommendation. See all recommendations here
  • For example, JP Morgan researcher Chris Schott (a top 13% rated analyst) recently reinstated his Strong Buy rating with a $22.00 price target, representing 30% upside potential from current levels.
  • Likewise, UBS researcher Ashwani Verma (a top 11% rated analyst) maintained his Strong Buy with a $25.00 price target, representing 48% upside potential from current levels.
  • Industry ranking context: AMRX is currently the #5 highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B.
  • Zen Ratings highlights: AMRX earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this tier have historically outperformed the broader market with nearly 30% annual returns.
  • Component Grades: AMRX earns solid Bs for Growth, Momentum, and Sentiment, a combination that reflects analyst conviction in the company's turnaround trajectory alongside improving execution across both its generic and specialty segments. See all 7 Component Grades here 

3- EnerSys (NYSE: ENS)

EnerSys manufactures and distributes reserve and motive power batteries for industrial applications, battery chargers and accessories, and power equipment. The company's strong position in energy storage solutions is capitalizing on growing demand from data centers, electric vehicles, and industrial automation, driving steady margin expansion.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $179.02 — get current quote

Max 1-year forecast: $280.00

Why we're watching:

  • ENS has limited, but overall bullish, coverage among the analysts we track, with 1 Strong Buy and 1 Buy recommendations. See all recommendations here
  • For example, BTIG researcher Gregory Lewis (a top 3% rated analyst) recently reiterated his Strong Buy rating with a $280.00 price target, representing 56% upside potential from current levels.
  • Additionally, Oppenheimer researcher Noah Kaye (a top 7% rated analyst) maintained his Buy with a $250.00 price target, representing 39% upside potential from current levels.
  • Industry ranking context: ENS is currently the #1 highest-rated stock in the Electrical Equipment & Parts industry, which has an Industry Rating of D.
  • Zen Ratings highlights: ENS earns an overall A rating, equal to a Strong Buy recommendation. This rating identifies stocks in the elite top 5% based on a comprehensive 115-factor evaluation framework.
  • Component Grades: ENS excels with strong As for Financials and Value alongside a solid B for Sentiment, Growth and Artificial Intelligence, reflecting the company's attractive valuation, healthy balance sheet, and compelling position in the rapidly expanding energy storage market. See all 7 Component Grades here

4- Semtech (NASDAQ: SMTC)

Semtech makes specialized chips and connectivity technology used in data centers and IoT devices. The company is gaining momentum as AI infrastructure and connected-device demand grow, with strong recent results showing its strategy is paying off.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $159.13 — get current quote

Max 1-year forecast: $300.00

Why we're watching:

  • SMTC has solid, bullish coverage among the analysts we track, with 8 Strong Buy, 6 Buy, and 1 Hold recommendations. See all recommendations here
  • For example, Baird researcher Craig Ellis (a top 1% rated analyst) recently maintained his Buy recommendation with a price target suggesting the stock could see greater than 89% upside in the coming year. 
  • More modest, but still pretty darned good, UBS researcher Timothy Arcuri (a top 1% rated analyst) maintained his Strong Buy with a price target suggesting the stock could see greater than 45% upside. 
  • Six additional top 1% analysts within our system all maintain bullish outlooks on the semiconductor sector's growth trajectory.
  • Industry ranking context: SMTC is currently the #3 highest-rated stock in the Semiconductor industry, which has an Industry Rating of A.
  • Zen Ratings highlights: SMTC earns an overall A rating, which amounts to a Strong Buy recommendation. This tier represents the elite top 5% of stocks tracked based on a rigorous 115-factor fundamental analysis.
  • Component Grades: SMTC excels with an A for Growth, and Financials alongside strong Bs for Momentum, Safety, and Sentiment, a combination that reflects the company's accelerating revenue trajectory and expanding market opportunities in data center infrastructure. See all 7 Component Grades here

5- Hewlett Packard Enterprise (NYSE: HPE)

HPE sells the servers, networking, and cloud infrastructure powering enterprise AI. Surging AI demand is lifting orders and growth, giving investors a more established way to play the AI infrastructure boom.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $55.22 — get current quote

Max 1-year forecast: $86.00

Why we're watching:

  • HPE has strong, bullish coverage among the analysts we track, with 10 Strong Buy, 2 Buy, and 5 Hold recommendations. See all recommendations here
  • For example, Citigroup researcher Asiya Merchant (a top 1% rated analyst) maintained her Strong Buy rating with a price target suggesting the stock could see nearly 30% upside in the coming year.  
  • It is our latest Stock of the Week… Our Editor-in-Chief recently extolled the company’s virtues after its latest earnings beat … See why he’s so bullish on HPE here.
  • Industry ranking context: HPE is currently the #1 highest-rated stock in the Communication Equipment industry, which has an Industry Rating of B.
  • Zen Ratings highlights: HPE earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
  • Component Grades: HPE excels with strong As for Growth and Sentiment, reflecting the company's positioning in high-growth AI and cloud markets alongside robust analyst optimism, while maintaining a solid B for Value that underscores its attractive entry point. See all 7 Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.